Where I see patients (3)
Selected research
-
Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research
-
PET Imaging Using 89Zr-Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention in Prostate Cancer.
Molecular cancer therapeutics
-
Millimeter-scale radioluminescent power for electronic sensors.
iScience
Clinical trials
Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma
Defined as the rate of lesions with positive uptake when compared against 18F-fluorodeoxyglucose (FDG) PET/computed tomography (CT) positivity. Sensitivity estimated based on lesion level without considering the location of the le...
Recruiting
PET Imaging Study of 89Zr-DFO-YS5 in Men with Prostate Cancer
For Cohort A, the optimal time point will be selected based on optimal maximun Standardized uptake value (SUVmax) of metastatic lesions, and ratio of SUVmax to blood pool. Due to the limited samples, the investigator will use all ...
Recruiting
Contact me
- Request appointment
- Refer a patient
- (415) 353-1968